Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Treatment of Cancer Patients from BMS Sponsored Trials
NCT03899155Phase 2Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2019
- Primary completion
- Aug 2029
- Modality
- Monoclonal Antibodies
- Countries
- 38
01
Overview
A Phase 2 trial of nivolumab in cancer, sponsored by Bristol Myers Squibb. Started Aug 2019; status: recruiting.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on NCT03899155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899155.